vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $196.0M, roughly 1.8× Axsome Therapeutics, Inc.). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs -14.6%, a 19.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 1.6%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 2.9%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
APOG vs AXSM — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $196.0M |
| Net Profit | $16.6M | $-28.6M |
| Gross Margin | 22.4% | — |
| Operating Margin | 7.3% | -13.8% |
| Net Margin | 4.7% | -14.6% |
| Revenue YoY | 1.6% | 65.0% |
| Net Profit YoY | 568.8% | 61.9% |
| EPS (diluted) | $0.78 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $196.0M | ||
| Q3 25 | $358.2M | $171.0M | ||
| Q2 25 | $346.6M | $150.0M | ||
| Q1 25 | $345.7M | $121.5M | ||
| Q4 24 | $341.3M | $118.8M | ||
| Q3 24 | $342.4M | $104.8M | ||
| Q2 24 | $331.5M | $87.2M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-28.6M | ||
| Q3 25 | $23.6M | $-47.2M | ||
| Q2 25 | $-2.7M | $-48.0M | ||
| Q1 25 | $2.5M | $-59.4M | ||
| Q4 24 | $21.0M | $-74.9M | ||
| Q3 24 | $30.6M | $-64.6M | ||
| Q2 24 | $31.0M | $-79.3M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | -13.8% | ||
| Q3 25 | 7.5% | -27.0% | ||
| Q2 25 | 2.0% | -24.5% | ||
| Q1 25 | 1.8% | -46.9% | ||
| Q4 24 | 8.4% | -61.1% | ||
| Q3 24 | 12.3% | -59.8% | ||
| Q2 24 | 12.5% | -89.5% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -14.6% | ||
| Q3 25 | 6.6% | -27.6% | ||
| Q2 25 | -0.8% | -32.0% | ||
| Q1 25 | 0.7% | -48.9% | ||
| Q4 24 | 6.1% | -63.1% | ||
| Q3 24 | 8.9% | -61.7% | ||
| Q2 24 | 9.4% | -91.0% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-0.55 | ||
| Q3 25 | $1.10 | $-0.94 | ||
| Q2 25 | $-0.13 | $-0.97 | ||
| Q1 25 | $0.12 | $-1.22 | ||
| Q4 24 | $0.96 | $-1.54 | ||
| Q3 24 | $1.40 | $-1.34 | ||
| Q2 24 | $1.41 | $-1.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $322.9M |
| Total DebtLower is stronger | $232.3M | — |
| Stockholders' EquityBook value | $511.8M | $88.3M |
| Total Assets | $1.1B | $689.8M |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $322.9M | ||
| Q3 25 | $39.5M | $325.3M | ||
| Q2 25 | $32.8M | $303.0M | ||
| Q1 25 | $41.4M | $300.9M | ||
| Q4 24 | $43.9M | $315.4M | ||
| Q3 24 | $51.0M | $327.3M | ||
| Q2 24 | $30.4M | $315.7M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $88.3M | ||
| Q3 25 | $500.2M | $73.7M | ||
| Q2 25 | $481.8M | $73.1M | ||
| Q1 25 | $487.9M | $53.2M | ||
| Q4 24 | $522.1M | $57.0M | ||
| Q3 24 | $506.4M | $92.9M | ||
| Q2 24 | $480.0M | $102.9M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $689.8M | ||
| Q3 25 | $1.2B | $669.3M | ||
| Q2 25 | $1.2B | $639.8M | ||
| Q1 25 | $1.2B | $596.7M | ||
| Q4 24 | $1.2B | $568.5M | ||
| Q3 24 | $917.1M | $561.5M | ||
| Q2 24 | $889.0M | $548.2M |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | $-18.7M |
| Free Cash FlowOCF − Capex | — | $-18.7M |
| FCF MarginFCF / Revenue | — | -9.6% |
| Capex IntensityCapex / Revenue | 7.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $-18.7M | ||
| Q3 25 | $57.1M | $1.0M | ||
| Q2 25 | $-19.8M | $-32.4M | ||
| Q1 25 | $30.0M | $-43.4M | ||
| Q4 24 | $31.0M | $-26.2M | ||
| Q3 24 | $58.7M | $-18.6M | ||
| Q2 24 | $5.5M | $-30.1M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $-18.7M | ||
| Q3 25 | $52.4M | $988.0K | ||
| Q2 25 | $-26.9M | $-32.4M | ||
| Q1 25 | $19.1M | $-43.7M | ||
| Q4 24 | $22.0M | $-26.2M | ||
| Q3 24 | $50.2M | $-18.7M | ||
| Q2 24 | $-1.8M | $-30.2M |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | -9.6% | ||
| Q3 25 | 14.6% | 0.6% | ||
| Q2 25 | -7.8% | -21.6% | ||
| Q1 25 | 5.5% | -36.0% | ||
| Q4 24 | 6.4% | -22.1% | ||
| Q3 24 | 14.7% | -17.9% | ||
| Q2 24 | -0.5% | -34.6% |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 3.2% | 0.3% | ||
| Q4 24 | 2.6% | 0.0% | ||
| Q3 24 | 2.5% | 0.1% | ||
| Q2 24 | 2.2% | 0.1% |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 0.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
AXSM
Segment breakdown not available.
